TPIDB > Principal Investigator
Principal Investigator
National Taiwan University Hospital
(在職)
Division of Hematology & Oncology
Division of Others-Department of Laboratory Medicine
Division of General Internal Medicine
更新時間：2023-09-19
周文堅Chou, Wen-Chien
- Principal Investigator
- Clinical Trial Experience (year) 17 years 9 個月
Publication
16Publications
1
Wang, Y. H., Lin, C. C., Hsu, C. L., Hung, S. Y., Yao, C. Y., Lee, S. H., . . . Tien, H. F. (2021). Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125. Annals of Hematology, 100(2), 487-498. doi:10.1007/s00277-020-04358-y
2
Tsai, C. H., Tang, J. L., Tien, F. M., Kuo, Y. Y., Wu, D. C., Lin, C. C., . . . Tien, H. F. (2021). Clinical implications of sequential MRD monitoring by NGS at 2 time points after chemotherapy in patients with AML. Blood Advances, 5(10), 2456-2466. doi:10.1182/bloodadvances.2020003738
3
Wang, Y. H., Lin, C. C., Lee, S. H., Tsai, C. H., Wu, S. J., Hou, H. A., . . . Tien, H. F. (2020). ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden. Blood Cancer Journal, 10(10). doi:10.1038/s41408-020-00364-5
4
Wang, Y. W., Tsai, C. H., Lin, C. C., Tien, F. M., Chen, Y. W., Lin, H. Y., . . . Tien, H. F. (2020). Cytogenetics and mutations could predict outcome in relapsed and refractory acute myeloid leukemia patients receiving BCL-2 inhibitor venetoclax. Annals of Hematology, 99(3), 501-511. doi:10.1007/s00277-020-03911-z
5
Liu, W. D., Lin, S. W., Shih, M. C., Su, C. L., Wang, Y. W., Lin, S. C., . . . Chang, S. C. (2020). False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration. Clinical Microbiology and Infection, 26(11). doi:10.1016/j.cmi.2020.02.002
6
Lin, CC., Yao, CY., Hsu, YC. et al. Knock-out of Hopx disrupts stemness and quiescence of hematopoietic stem cells in mice. Oncogene 39, 5112–5123 (2020). https://doi.org/10.1038/s41388-020-1340-2
7
Hung, S. Y., Lin, C. C., Hsu, C. L., Yao, C. Y., Wang, Y. H., Tsai, C. H., . . . Tien, H. F. (2021). The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes. British Journal of Haematology, 192(3), 589-598. doi:10.1111/bjh.17231
8
Wang, Y. H., Lin, C. C., Yao, C. Y., Hsu, C. L., Hou, H. A., Tsai, C. H., . . . Tien, H. F. (2020). A 4-gene leukemic stem cell score can independently predict the prognosis of myelodysplastic syndrome patients. Blood Advances, 4(4), 644-654. doi:10.1182/bloodadvances.2019001185
9
Tsai, C. H., Yao, C. Y., Tien, F. M., Tang, J. L., Kuo, Y. Y., Chiu, Y. C., . . . Tien, H. F. (2019). Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients. Ebiomedicine, 40, 240-250. doi:10.1016/j.ebiom.2019.01.022
10
Sakurai, M., Jang, J. H., Chou, W. C., Kim, J. S., Wilson, A., Nishimura, J., . . . Okamoto, S. (2019). Comparative study on baseline clinical characteristics of Asian versus non-Asian patients with paroxysmal nocturnal hemoglobinuria. International Journal of Hematology, 110(4), 411-418. doi:10.1007/s12185-019-02699-7
1
2
